TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3 to $4.
TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3 to $4.